Health care workers’ experiences with implementation of “screen and treat” for cervical cancer prevention in Malawi: A qualitative study

被引:2
作者
Moucheraud C. [1 ]
Kawale P. [2 ]
Kafwafwa S. [3 ]
Bastani R. [1 ]
Hoffman R.M. [4 ]
机构
[1] University of California Fielding School of Public Health, Los Angeles, CA
[2] African Institute for Development Policy, Lilongwe
[3] Partners in Hope Medical Center, Lilongwe
[4] University of California Geffen School of Medicine, Los Angeles, CA
来源
Implementation Science Communications | / 1卷 / 1期
基金
美国国家卫生研究院;
关键词
Cervical cancer; CFIR; Global health; Screening;
D O I
10.1186/s43058-020-00097-3
中图分类号
学科分类号
摘要
Background: Cervical cancer remains a major cause of mortality and morbidity in low- and middle-income countries, despite the availability of effective prevention approaches. “Screen and treat” (a single-visit strategy to identify and remove abnormal cervical cells) is the recommended secondary prevention approach in low-resource settings, but there has been relatively scarce robust implementation science evidence on barriers and facilitators to providing “screen and treat” from the provider perspective, or about thermocoagulation as a lesion removal technique. Methods: Informed by the Consolidated Framework for Implementation Research (CFIR), we conducted interviews with ten experienced “screen and treat” providers in Malawi. We asked questions based on the CFIR Guide, used the CFIR Guide codebook for a descriptive analysis in NVivo, and added recommended modifications for studies in low-income settings. Results: Seven CFIR constructs were identified as positively influencing implementation, and six as negatively influencing implementation. The two strong positive influences were the relative advantage of thermocoagulation versus cryotherapy (Innovation Characteristics) and respondents’ knowledge and beliefs about providing “screen and treat” (Individual Characteristics). The two strong negative influences were the availability of ongoing refresher trainings to stay up-to-date on skills (Inner Setting, Implementation Climate) and insufficient resources (staffing, infrastructure, supplies) to provide “screen and treat” to all women who need it (Inner Setting, Readiness for Implementation). Weak positive factors included perceived scalability and access to knowledge/information, as well as compatibility, leadership engagement, and team characteristics, but these latter three were mixed in valence. Weak negative influences were structural characteristics and donor priorities; and mixed but weakly negative influences were relative priority and engaging clients. Cross-cutting themes included the importance of broad buy-in (including different cadres of health workers and leadership at the facility and in the government) and the opportunities and challenges of offering integrated care (screening plus other services). Conclusions: Although “screen and treat” is viewed as effective and important, many implementation barriers remain. Our findings suggest that implementation strategies will need to be multi-level, include a diverse set of stakeholders, and explicitly address both screening and treatment. © 2020, The Author(s).
引用
收藏
相关论文
共 62 条
  • [1] Schiffman M., Castle P.E., The promise of global cervical-cancer prevention, New Engl J Med, 353, 20, pp. 2101-2104, (2005)
  • [2] Canfell K., Towards the global elimination of cervical cancer, Papillomavirus Res, 8, (2019)
  • [3] WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention, Geneva: World Health Organization, (2013)
  • [4] Olson B., Gribble B., Dias J., Curryer C., Vo K., Kowal P., Byles J., Cervical cancer screening programs and guidelines in low- and middle-income countries, Int J Gynecol Obstet, 134, 3, pp. 239-246, (2016)
  • [5] Simms K.T., Steinberg J., Caruana M., Smith M.A., Lew J.-B., Soerjomataram I., Castle P.E., Bray F., Canfell K., Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study, Lancet Oncol, 20, 3, pp. 394-407, (2019)
  • [6] Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 6, pp. 394-424, (2018)
  • [7] Arbyn M., Weiderpass E., Bruni L., de Sanjose S., Saraiya M., Ferlay J., Bray F., Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis, Lancet Glob Health, 8, 2, pp. E191-E203, (2019)
  • [8] de Fouw M., Oosting R.M., Rutgrink A., Dekkers O.M., Aaw P., Beltman J.J., A systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries, Int J Gynecol Obstet, 147, 1, pp. 4-18, (2019)
  • [9] World Health O., WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions, (2019)
  • [10] Campbell C., Kafwafwa S., Brown H., Walker G., Madetsa B., Deeny M., Kabota B., Morton D., Ter Haar R., Grant L., Use of thermo-coagulation as an alternative treatment modality in a ‘screen-and-treat’ programme of cervical screening in rural Malawi, Int J Cancer, 139, 4, pp. 908-915, (2016)